RRM1 and adrenal cortex carcinoma: Our findings, however, clearly indicate that there are strong modulations of RRM1, 2, and 2B gene expression, protein abundance, and subsequent activity in ACC models during/upon therapy by various chemotherapeutic drugs, such as gemcitabine, cisplatin, etoposide, and doxorubicin.